Trial Profile
A randomized, open-label clinical study of lixisenatide or titrated insulin glargine, followed by their combined administration with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2018
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Jul 2018 New trial record